Top Markets
Coin of the day
Mercury Biopharmaceutical Corporation Mercury Biopharmaceutical Corporation

Mercury Biopharmaceutical Corporation

6932
Kedudukan dalam Saham #23452
Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury... Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury Biopharmaceutical Corporation is dedicated to creating innovative pharmaceutical solutions for medical conditions currently lacking adequate treatment options. A cornerstone of their strategy is the proprietary StackDose platform, an advanced drug development system designed to formulate novel medication delivery methods. This platform facilitates precisely timed drug release, targeted absorption at specific locations within the body, and flexible dosage modifications. The primary objective of StackDose is to significantly boost the bioavailability of active pharmaceutical ingredients, leading to a reduction in required drug dosages and fewer adverse effects. Their development pipeline currently addresses a variety of ailments, such as erectile dysfunction, pulmonary hypertension, sleep disturbances, benign prostatic hyperplasia, angina, migraines, hypertension, and pain management.
Harga Saham
$0.17616661
Disegerakkan terakhir: 2026-08-21
Modal Pasaran
$73.48M
Perubahan (1 hari)
0.18%
Perubahan (1 tahun)
-37.76%
Negara
TW
Perdagangan Mercury Biopharmaceutical Corporation (6932)

Kategori

Sejarah pecahan saham untuk Mercury Biopharmaceutical Corporation (6932)
Saham Mercury Biopharmaceutical Corporation (simbol: 6932) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 22, 2026.
Satu saham 6932 yang dibeli sebelum Aug 22, 2026 kini bersamaan dengan 0 saham 6932.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa